Have a personal or library account? Click to login
Ocular ischemic syndrome – case report and literature analysis Cover

References

  1. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. Aug 2012;18(8):RA138–144.
  2. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. Jan–Feb 2010;55(1):2–34.
  3. Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP; International Society for Clinical Electrophysiology of Vision. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133:1–9..
  4. Kearns TP, Hollenhorst RW. Venous stasis retinopathy of occlusive disease of the carotid artery. Mayo Clin Proc. 1963;38:304–12.
  5. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol 2010;55:2–34.
  6. Hung JH, Chang YS. Ocular ischemic syndrome. CMAJ. 12 June 2017;189(23):E804.
  7. Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104:859–64.
  8. Sharma S, Brown GC. In: Ocular Ischemic Syndrome. Ryan SJ, Hinton DR, Schachat AP, et al., editors. Elsevier; 2006.
  9. Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol. 1991;15(1):15–20.
  10. Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11(4):239–51.
  11. Kerty E, Eide N. Chronic ocular ischaemia. Acta Ophthalmol. 1989;67(4):386–92.
  12. Brown GC. Macular edema in association with severe carotid artery obstruction. Am J Ophthalmol. 1986;102(4):442–48.
  13. Berkow JW, Flower RW, Orth DH, Kelley JS. Angiografia fluoresceinowa i indocyjaninowa. Wrocław: Górnicki Wydawnictwo Medyczne; 2004.
  14. Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. 2007;8(1):17–28.
  15. Hashimoto M, Ohtsuka K, Ohtsuka H, Nakagawa T. Normal-tension glaucoma with reversed ophthalmic artery flow. Am J Ophthalmol. 2000;130(5):670–72.
  16. Kofoed PK, Munch IC, Sander B, Holfort SK, Sillesen H, Jensen LP, Larsen M. Prolonged multifocal electroretinographic implicit times in the ocular ischemic syndrome. Invest Ophthalmol Vis Sci. 2010;51:1806–10.
  17. Duker, J. S., Brown, G. C., Bosley, T. M., Colt, C. A., & Reber, R. Asymmetric proliferative diabetic retinopathy and carotid artery disease. Ophthalmology. 1990;97(7):869–874.
  18. Jingyi L, Zhichao Y, Yu J, Rongjiang L. Clinical analysis of 42 cases of ocular ischemic syndrome. Journal of Ophthalmology. 2018.
  19. Wierzbowska J, Robaszkiewicz J, Figurska M, Stankiewicz A. Future possibilities in glaucoma therapy. Med Sci Monit. 2010;16:RA252–9.
  20. Dzierwa K, Pieniazek P, Musialek P, Piatek J, Tekieli L, Podolec P, Drwiła R, Hlawaty M, Trystuła M, Motyl R, et al. Treatment strategies in severe symptomatic carotid and coronary artery disease. Med Sci Monit. 2011;17:RA191–197.
Language: English
Page range: 1 - 4
Submitted on: Jun 21, 2023
Accepted on: Jan 5, 2024
Published on: Mar 5, 2024
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Aleksandra Górska, Marek Sosnowski, Sebastian Sirek, Rafał Leszczyński, Mikołaj Kuźniak, Ewa Mrukwa-Kominek, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.